Evidence map›Paper›PMID 26432982›Full record

ReviewCellular microbiology2015

Molecular weaponry: diverse effectors delivered by the Type VI secretion system.

Juliana Alcoforado Diniz, Yi-Chia Liu, Sarah J Coulthurst

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 170 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. An electron transport complex required in the gut sensitizesProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Infection and immunity · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. First whole genome report ofCurrent research in microbial sciences · 2025
    Article
  18. Article
  19. Infection and immunity · 2024
    Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Juliana Alcoforado DinizDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
Yi-Chia LiuDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
Sarah J CoulthurstDivision of Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
University of Dundee · GB

Funding

Wellcome Trust 104556
6 · The paper itself

Abstract

The Type VI secretion system is a widespread bacterial nanomachine, used to deliver toxins directly into eukaryotic or prokaryotic target cells. These secreted toxins, or effectors, act on diverse cellular targets, and their action provides the attacking bacterial cell with a significant fitness advantage, either against rival bacteria or eukaryotic host organisms. In this review, we discuss the delivery of diverse effectors by the Type VI secretion system, the modes of action of the so-called 'anti-bacterial' and 'anti-eukaryotic' effectors, the mechanism of self-resistance against anti-bacterial effectors and the evolutionary implications of horizontal transfer of Type VI secretion system-associated toxins. Whilst it is likely that many more effectors remain to be identified, it is already clear that toxins delivered by this secretion system represent efficient weapons against both bacteria and eukaryotes.

Indexed as

AntibiosisBacteriaBacterial ToxinsCell SurvivalEukaryotic CellsMicrobial ViabilityType VI Secretion SystemsVirulenceVirulence FactorsBacterial ToxinsType VI Secretion SystemsVirulence Factors

Identifiers

PMID26432982
PMCPMC4832377
OpenAlexW1899329792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.